Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs
المصدر: Fox News | Source: Fox NewsPresident Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs."
"These treatments are currently in the advanced stages of clinical trials to ensure that they're both safe and effective for the American patients," he added.
The president said the executive order would implement "historic reforms to dramatically accelerate access to new medical research and treatments based on psychedelic drugs."
"In many cases, these experimental treatments have shown life changing potential for those suffering from severe mental illness and depression, including our cherished veterans," Trump said, citing the veteran suicide rate.
This is a developing story. Please check back for updates.
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة Fox News. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Fox News. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.
